Australian ocular technology company Eye Co Pty Ltd has achieved a key commercial milestone, with a patent granted protecting its new class of eye disease drugs throughout the high value European market.
Uncategorized
Demographics and demand spur innovation in ophthalmology
Despite recent advances, lens surgeries such as cataract extraction or secondary IOL implantation in vitrectomized eyes remain challenging. Eyes with deficient capsules with a primary vitreoretinal procedure requiring silicone oil injection often require silicone oil removal and visual rehabilitation by secondary IOL implantation. Combining silicone oil removal with glued IOL implantation in a single sitting has advantages compared with a two-step procedure. It negates a second surgical procedure for IOL implantation, which minimizes the overall treatment time, reduces the risk of anesthetic complications and achieves a faster visual rehabilitation while (Read more...)
American Academy of Ophthalmology (AAO) 2014 Annual Meeting
Read clinically focused news coverage of key developments from AAO 2014. Medscape Ophthalmology
Sneak Peek at AAO 2014
Dr Roger Steinert outlines the popular and not-to-miss sessions at this year’s American Academy of Ophthalmology meeting, and for those who can’t make it, the ‘virtual meeting’ is an option. Medscape Ophthalmology
Uncategorized
Toric IOL rotation seen in eyes with long axial length
Toric IOLs corrected preexisting corneal astigmatism and showed good overall long-term rotational stability after cataract surgery; however, significant IOL rotation was seen in eyes with relatively long axial lengths and with-the-rule astigmatism, acc…
Uncategorized
DMEK graft rejection rate low with postoperative corticosteroids
Descemet’s membrane endothelial keratoplasty yielded a low graft rejection rate at 1 year with high- and low-dose postoperative topical corticosteroids, according to study findings.The prospective, randomized, open-label, controlled trial included 325 eyes that underwent Descemet’s membrane endothelial keratoplasty (DMEK); 297 eyes completed the study.